World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR2761
Date of registration: 11/02/2011
Primary sponsor: University Medical Center Nijmegen
Public title: Effect of Pregabaline and S-Ketamine on knee function after total knee arthroplasty.
Scientific title: Does the addition of Pregabaline and S-Ketamine to local knee infiltration improve the postoperative knee function after total knee arthroplasty? - THE EFFECT OF PREGABALIN AND S-KETAMINE ON THE KNEE FUNCTION OUTCOME, AFTER TOTAL KNEE ARTHROPLASTY
Date of first enrolment: 1/4/2011
Target sample size: 60
Recruitment status: pending
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2761
Study type:  intervention
Study design:  Randomised: Yes; Masking: Double; Control: Placebo; Group: Parallel; Type: Single arm  
Countries of recruitment
The Netherlands
Contacts
Name: Oliver H.G.   Wilder-Smith
Address:  Department of Anaesthesiology Radboud University Nijmegen Medical Centre POB 9101 6500 HB Nijmegen The Netherlands
Telephone: +31 (0)24 3668120
Email: o.wildersmith@anes.umcn.nl
Affiliation: 
Name: Lajla  Kadic
Address:  Postbus 9101, Universitair Medisch Centrum St Radboud Afdeling Anesthesiologie, Pijn- en Palliatieve Geneeskunde Huispost 630, route 630 6500 HB Nijmegen The Netherlands
Telephone: +31 (0)24 3614406
Email: l.kadic@anes.umcn.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients aged 18 to 80 years, listed for total knee arthroplasty are eligible for this study.

Exclusion criteria: 1. Patient refusal;

2. Preexisting neurological or psychiatric illnesses;

3. Chronic pain syndrome;

4. Alcohol or drug abuse;

5. Difficulties in communication or expected inability to understand patient-controlled analgesia;

6. Rheumatoid arthritis;

7. Revision knee surgery;

8. Participation in another study.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Total knee arthroplasty, S(+)-ketamine, Local knee infiltration

Intervention(s)
In the study group, 150 mg of pregabalin will be given per os with premedication. It will be continued, twice a day during the first three postoperative days. The dose will be reduced to 75 mg two times a day in elderly patients. The control group will get placebo.



At the beginning of the surgery, the study group will also receive an intravenous bolus of 5-10 mg S-ketamine. This will be followed by a 24 hours continuous infusion, at the rate of 5-10 mg/hour (dose reduction for elderly).The control group will get normal saline infusion instead.
Primary Outcome(s)
1. Range of motion / Knee flexion angle: The knee flexion angle is measured from the first postoperative day (Day 1), until the day of discharge (DD), by a physical therapist (flexion_1,flexion _2, flexion_3, flexion_4, flexion_5, flexion_DD);

2. Pain: The standard Numeric Rating Scale (NRS) is used to measure pain. The patient can grade the intensity of knee related pain on a scale of 0-10, where 0 means no pain and 10 is the worst imaginable pain. The NRS is recorded on the day 0 in the recovery: NRS0-R, and in the ward: NRS0-W; on the day 1 (NRS1 four times a day); on the day 2 (NRS2 four times a day) by a nurse on the ward. From day one to day five, a physical therapist will note the dynamic pain scores (NRS-d), during the exercises (NRS1-d to NRS5-d);

3. Piritramide consumption: All patients are instructed to use PCA-piritramide, if they have knee pain. They may receive a 1 mg piritramide on demand, during the first 48 hours. Piritramide is given as a rescue medication and the total consumption per day will be noted;

4. S-Ketamine / pregabalin possible side effects;

5. The state of sedation will be assessed as a 4-point score:
0 = no sedation, 1 = mild sedation, 2 = moderate sedation, 3 = severe sedation during the first 24 hours;

6. Postoperative nausea and vomiting: PONV will be registered as: absent, mild or heavy;

7. Length of hospital stay: The length of hospital stay is noted as the number of days between the day of surgery and discharge from the hospital (or readiness to discharge);

8. Patients` satisfaction: The patient?s satisfaction with the postoperative analgesia is recorded before discharge. This is done on a 4 point scale; 1 = poor, 2 = fair, 3 = good, or 4 = excellent.
Secondary Outcome(s)
An independent physician measures the knee function six weeks, three months and one year after surgery. In addition, pain at rest and movement wil be scored, and the satisfaction with the TKA assessed, each time.
The Knee Society score (KSS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaires are used. The KSS is divided in a part with knee related questions (KSS_knee) and a functional scale (KSS_function). The WOMAC is divided in a pain scale (WOMAC_pain), stiffness scale (WOMAC_stiffness) and a functional scale (WOMAC_function). All subscales of the KSS and WOMAC have a range of 0-100.
Secondary ID(s)
35558
Source(s) of Monetary Support
University Medical Center Nijmegen
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history